InvestorsHub Logo
Followers 68
Posts 2195
Boards Moderated 0
Alias Born 03/04/2018

Re: GD post# 387884

Friday, 12/02/2022 12:56:26 PM

Friday, December 02, 2022 12:56:26 PM

Post# of 469269
Yes if the data was as good as the PR headline, the SP would be around $30.

I agree with your timeline If Anavex gets a trial up by summer/fall 2023, and take 1 year for recruitment (optimistic if they don't add many ex-AU sites) and use 48 weeks then the data could be out by early 2026 best case. This is what happens when you begin with a crappy 2a (32 patients), data mine it to death rather than have a proper 200 patient phase 2 to actually figure out the right dose and endpoints. We went from being 2 years ahead of SAVA to 2 years behind.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News